Lacosamide Tablet
Product Images NDC 53746-923

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 53746-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 1)

Chemical structure diagram of the active ingredient lacosamide, showing its molecular arrangement including functional groups and bonds typical of this compound.*

FDA Label Image

2 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 2)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose.' It compares seizure reduction percentages for placebo and Lacosamide at doses of 200, 400, and 600 mg/day across three studies (Study 2, Study 3, Study 4). The chart shows higher median percent seizure reductions for Lacosamide doses compared to placebo, with statistical significance noted for several Lacosamide dose groups.*

FDA Label Image

3 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 3)

A line graph titled 'Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4' showing responder rate (equal to or greater on the positive side and worsening on the negative side) on the vertical axis and percent of patients on the horizontal axis. Four lines represent different groups: Placebo (N=359), Lacosamide 200 mg/day (N=267), Lacosamide 400 mg/day (N=466), and Lacosamide 600 mg/day (N=202). The graph depicts comparative responder rates across patient percentages for the placebo and varying dosages of Lacosamide.*

FDA Label Image

4 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 4)

Lacosamide 50 mg tablets bottle label by Amneal Pharmaceuticals of New York LLC. The label indicates 60 tablets per bottle and is labeled for oral human prescription use. It includes storage instructions, a QR code for medication guides, and notes the product is Rx only with a beige and white background.*

FDA Label Image

5 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 5)

Lacosamide Tablets, USP 100 mg oral tablets label by Amneal Pharmaceuticals of New York LLC. The label indicates 60 tablets per container, with instructions to dispense the Medication Guide to each patient. Includes storage information, Rx only designation, and a barcode. The label also features a QR code linking to medication guides online.*

FDA Label Image

6 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 6)

Label for Lacosamide Tablets USP 150 mg by Amneal Pharmaceuticals of New York LLC. The label indicates 60 film-coated tablets per bottle, prescription only. Directions include dispensing the Medication Guide with each patient. Storage and safety instructions are provided, along with a QR code for additional medication guides. The label includes NDC 53746-925-60 and packaging details in a purple, white, and black color scheme.*

FDA Label Image

7 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 7)

Lacosamide Tablets, USP 200 mg oral tablets packaged by Amneal Pharmaceuticals of New York LLC. The label indicates 60 tablets per container and includes storage instructions and a pharmacist dispensing note. The label features the Amneal logo and a QR code linking to medication guides.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.